ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) Research & Development: ₺0.00 Mil (TTM As of Mar. 2026)


IST:ICUGS ICU Girisim Sermayesi Yatirim Ortakligi AS IST:ICUGS
15 GF Score
Price ₺5.65
View Full Analysis

What is ICU Girisim Sermayesi Yatirim Ortakligi AS Research & Development?

ICU Girisim Sermayesi Yatirim Ortakligi AS IST:ICUGS 15 Research & Development is ₺0.00 Mil as of Mar. 2026. GuruFocus rates IST:ICUGS with a GF Score™ of 15/100.

Research & Development is the aggregate amount of research and development expenses during the year. ICU Girisim Sermayesi Yatirim Ortakligi AS's Research & Development for the three months ended in Mar. 2026 was ₺0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₺0.00 Mil.

ICU Girisim Sermayesi Yatirim Ortakligi AS  (IST:ICUGS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ICU Girisim Sermayesi Yatirim Ortakligi AS Research & Development Related Terms

ICU Girisim Sermayesi Yatirim Ortakligi AS Research & Development Historical Data

* Premium members only.

The historical data trend for ICU Girisim Sermayesi Yatirim Ortakligi AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICU Girisim Sermayesi Yatirim Ortakligi AS Research & Development Chart

ICU Girisim Sermayesi Yatirim Ortakligi AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ICU Girisim Sermayesi Yatirim Ortakligi AS Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
IST:ICUGS
15GF Score
ICU Girisim Sermayesi Yatirim Ortakligi AS IST:ICUGS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ICU Girisim Sermayesi Yatirim Ortakligi AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₺0.00 Mil mean?
ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) has a Research & Development of ₺0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on ICU Girisim Sermayesi Yatirim Ortakligi AS and its competitors.
Is ICU Girisim Sermayesi Yatirim Ortakligi AS's Research & Development too high?
ICU Girisim Sermayesi Yatirim Ortakligi AS's current Research & Development is ₺0.00 Mil. Overall, ICU Girisim Sermayesi Yatirim Ortakligi AS has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ICU Girisim Sermayesi Yatirim Ortakligi AS's Research & Development compare to BLK and BX?
ICU Girisim Sermayesi Yatirim Ortakligi AS's Research & Development of ₺0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on ICU Girisim Sermayesi Yatirim Ortakligi AS and its competitors. ICU Girisim Sermayesi Yatirim Ortakligi AS's current Research & Development is ₺0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Girisim Sermayesi Yatirim Ortakligi AS stock overvalued right now?
ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) has a current Research & Development of ₺0.00 Mil. The current Research & Development is ₺0.00 Mil. ICU Girisim Sermayesi Yatirim Ortakligi AS's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS), the current Research & Development is ₺0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ICU Girisim Sermayesi Yatirim Ortakligi AS Business Description

Address Sair Esref Boulevard Ragip Samli Business Center, Block No. 6 Ic Kapi No. 706, Ismet Kaptan District, Izmir, Konak, TUR, 34398
ICU Girisim Sermayesi Yatirim Ortakligi AS is a Turkey based investment banking company. It operates as a venture capital company. The company invests in portfolio of companies which includes OEP RHEA Turkey Tech, Seta Medical, Netsafe Information System, and RML Lines.
15GF Score

Get the complete analysis for IST:ICUGS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺5.65
Price